Original combined cardiological preparation for coronary heart disease treatment.
Composition: magladen in terms of 100 % substance with content of sum of adenine nucleotides 18.6 — 29.25 mg, molsidominum in terms of 100 % substance 0.3 mg, folic acid in terms of 100 % substance 0.45 mg.
Release form: tablets No. 30 (10x 3)
Description: original combined cardiological preparation for coronary heart disease treatment. Owing to unique composition it permits to increase the resistance of heart cells against ischemia and physical stresses. Main effect of the preparation is the preconditioning effect creation — «heart cells hardening».
— Stenocardia without headache
— Not addictive
— Complex treatment